ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2731

Illness Perceptions and Health-Related Quality of Life in Patients with Axial Spondyloarthritis and Other Forms of Chronic Back Pain in the Spondyloarthritis Caught Early (SPACE)-Cohort

Miranda van Lunteren1, Pauline Bakker1, Margreet Scharloo2, Ad Kaptein3, Zineb Ez-Zaitouni1, Camilla Fongen4, Robert Landewé5, Maikel van Oosterhout6, Mariagrazia Lorenzin7, Désirée van der Heijde1 and Floris van Gaalen1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Medical Psychology, Leiden University Medical Center, Leiden, Netherlands, 4Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 5Rheumatology, Academic Medical Center, Amsterdam, Netherlands, 6Rheumatology, Groene Hart Ziekenhuis, Gouda, Netherlands, 7Rheumatology Unit, Department of Medicine DIMED, Rheumatology Unit,University of Padova, Padova, Italy

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: axial spondyloarthritis, chronic low back pain and quality of life

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Knowledge about the impact of illness perceptions on health-related quality of life (HRQoL) in patients with axial Spondyloarthritis (axSpA) and other forms of chronic back pain (CBP) is lacking. The aim is to explore the association between illness perceptions and HRQoL in patients with short symptom duration of axSpA and other forms of CBP at baseline.

Methods: The SPACE study includes patients with CBP (≥3 months, ≤2 years, onset <45 years) from 5 European centers. Revised Illness Perception Questionnaire (IPQ-R) was completed at baseline. In illness identity dimension, patients reported if they have experienced and believed that a certain symptom is CBP related. Other IPQ-R dimensions used 5-point Likert scales (1 strongly disagree, 5 strongly agree). HRQoL was assessed by 36-item Short-Form (SF-36). Physical (PCS) and Mental Component Summary (MCS) scores were calculated ranging from 0 (worst) to 100 (best). Univariable regression models were built for each IPQ-R subscale as independent and PCS or MCS as dependent variable. The models were adjusted for age and gender and stratified in case of effect modification by gender (p<0.20).

Results: 450 patients were included; 176 fulfilled the axSpA ASAS criteria. Mean PCS was 28.3 (SD 16.1) for axSpA patients and 25.4 (SD 14.8) for CBP. As the MCS was only slightly decreased compared to the general population of 50 (SD 10) (48.8 (SD 13.7) axSpA and 48.3 (SD 12.1) CBP patients), analyses focused on PCS. Patients reported a mean of 4.3 (axSpA) and 4.5 (CBP) symptoms to be associated with back pain. Most reported symptoms were pain and joint stiffness. All other dimensions showed a mean of approximately 3, except psychological attributions, risk factors, immunity, and accident (mean approximately 2). All patients attributed their complaints mostly to genetic factors. In both patient groups attribution of multiple symptoms to CBP (Table 1; β=-1.9 axSpA, β=-2.0 CBP) was associated with lower PCS. Stronger belief in severe consequences in male axSpA patients (β=-11.3) and stronger belief in risk factors (β=-6.9) or immunity (β=-8.3) as a cause in male CBP patients were associated with lower PCS. Whereas, in male axSpA patients, being better in understanding their complaints (β=6.2) was associated with higher PCS. In female axSpA patients stronger belief in severe consequences (β=-7.3) and in female CBP patients more negative emotions towards their complaints (β=-3.8) and being better in understanding their complaints (β=3.3) were statistically significant. No gender differences were found for emotional representation (β=-5.0), psychological attributions (β=-3.4), immunity (β=-4.0), or accident (β=-3.0) in axSpA and consequences (β=-8.5) or chance (β=-2.0) in CBP patients.

Conclusion: Negative illness perceptions are associated with lower PCS of HRQoL in patients with axSpA and other forms of CBP.


Disclosure: M. van Lunteren, None; P. Bakker, None; M. Scharloo, None; A. Kaptein, None; Z. Ez-Zaitouni, None; C. Fongen, None; R. Landewé, None; M. van Oosterhout, None; M. Lorenzin, None; D. van der Heijde, None; F. van Gaalen, None.

To cite this abstract in AMA style:

van Lunteren M, Bakker P, Scharloo M, Kaptein A, Ez-Zaitouni Z, Fongen C, Landewé R, van Oosterhout M, Lorenzin M, van der Heijde D, van Gaalen F. Illness Perceptions and Health-Related Quality of Life in Patients with Axial Spondyloarthritis and Other Forms of Chronic Back Pain in the Spondyloarthritis Caught Early (SPACE)-Cohort [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/illness-perceptions-and-health-related-quality-of-life-in-patients-with-axial-spondyloarthritis-and-other-forms-of-chronic-back-pain-in-the-spondyloarthritis-caught-early-space-cohort/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/illness-perceptions-and-health-related-quality-of-life-in-patients-with-axial-spondyloarthritis-and-other-forms-of-chronic-back-pain-in-the-spondyloarthritis-caught-early-space-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology